Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms

Nature Communications

Volumn 5, Issue , 2014, Pages

  Yan, Haijing ^a   Zhang, Xiangnan ^a,b   Hu, Weiwei ^a,b   Ma, Jing ^a   Hou, Weiwei ^a   Zhang, Xingzhou ^a   Wang, Xiaofen ^a,c   Gao, Jieqiong ^a,c   Shen, Yao ^a,c   Lv, Jianxin ^c   Ohtsu, Hiroshi ^d   Han, Feng ^a   Wang, Guanghui ^e   Chen, Zhong ^a,b  

^a BEIJING HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; CHLORIDE CHANNEL; CHLORIDE INTRACELLULAR CHANNEL 4; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; MAMMALIAN TARGET OF RAPAMYCIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ATG5 PROTEIN, MOUSE; CLIC PROTEIN, MOUSE; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN;

ANTAGONISM; CHEMICAL BINDING; ENZYME ACTIVITY; GENE EXPRESSION; INJURY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BRAIN CELL; BRAIN ISCHEMIA; CONTROLLED STUDY; FIBROBLAST; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; UPREGULATION; ANIMAL; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; CHLORIDE CHANNELS; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE H3 ANTAGONISTS; HISTIDINE DECARBOXYLASE; MALE; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL PROTEINS; RECEPTORS, HISTAMINE H3;

EID: 84896806053     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4334     Document Type: Article

References (53)

1. Dirnagl, U., Iadecola, C. & Moskowitz, M. A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397 (1999). (Pubitemid 29453643)
2. Koroshetz, W. J. Tissue plasminogen activator for acute ischemic stroke. New Engl. J. Med. 334, 1405-1406 (1996). (Pubitemid 26152726)
3. Green, A. R. & Shuaib, A. Therapeutic strategies for the treatment of stroke. Drug Discov. Today 11, 681-693 (2006). (Pubitemid 44056287)
4. Takagi, H. et al. Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker. Brain Res. 364, 114-123 (1986). (Pubitemid 16149021)
5. Haas, H. & Panula, P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat. Rev. Neurosci. 4, 121-130 (2003). (Pubitemid 37271382)
6. Haas, H. L., Sergeeva, O. A. & Selbach, O. Histamine in the nervous system. Physiol. Rev. 88, 1183-1241 (2008).
7. Brown, R. E., Stevens, D. R. & Haas, H. L. The physiology of brain histamine. Prog. Neurobiol. 63, 637-672 (2001). (Pubitemid 32119421)
8. Arrang, J. M., Garbarg, M. & Schwartz, J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832-837 (1983). (Pubitemid 13125123)
9. Morisset, S. et al. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408, 860-864 (2000). (Pubitemid 32016096)
10. Schlicker, E., Betz, R. & Gothert, M. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch. Pharmacol. 337, 588-590 (1988).
11. Schlicker, E., Fink, K., Hinterthaner, M. & Gothert, M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 340, 633-638 (1989). (Pubitemid 20023150)
12. Schlicker, E., Fink, K., Detzner, M. & Gothert, M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J. Neural Transm. 93, 1-10 (1993). (Pubitemid 23235613)
13. Clapham, J. & Kilpatrick, G. J. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br. J. Pharmacol. 107, 919-923 (1992).
14. Leurs, R., Bakker, R. A., Timmerman, H. & de Esch, I. J. The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat. Rev. Drug Discov. 4, 107-120 (2005). (Pubitemid 40277492)
15. Bongers, G. et al. The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J. Neurochem. 103, 248-258 (2007). (Pubitemid 47404216)
16. Jope, R. S. & Johnson, G. V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102 (2004). (Pubitemid 38186580)
17. Medhurst, S. J. et al. Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain. Pain 138, 61-69 (2008).
18. Hsieh, G. C. et al. Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems. Brain Res. 1354, 74-84 (2010).
19. Yokoyama, H. et al. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur. J. Pharmacol. 260, 23-28 (1994). (Pubitemid 24227418)
20. Kakinoki, H., Ishizawa, K., Fukunaga, M., Fujii, Y. & Kamei, C. The effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in rats. Brain Res. Bull. 46, 461-465 (1998). (Pubitemid 28401874)
21. Dai, H. et al. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. Eur. J. Pharmacol. 563, 117-123 (2007). (Pubitemid 46602226)
22. Akhtar, M., Pillai, K. & Vohora, D. Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model of focal cerebral ischemia in rats. Hum. Exp. Toxicol. 27, 761-767 (2008).
23. Broughton, B. R., Reutens, D. C. & Sobey, C. G. Apoptotic mechanisms after cerebral ischemia. Stroke 40, e331-e339 (2009).
24. Adhami, F., Schloemer, A. & Kuan, C. Y. The roles of autophagy in cerebral ischemia. Autophagy 3, 42-44 (2007).
25. Wen, Y. D. et al. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy 4, 762-769 (2008).
26. Yang, Y. P., Liang, Z. Q., Gu, Z. L. & Qin, Z. H. Molecular mechanism and regulation of autophagy. Acta Pharmacol. Sin. 26, 1421-1434 (2005).
27. Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M. & Sadoshima, J. Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion. Circ. Res. 109, 502-511 (2011).
28. Hamacher-Brady, A., Brady, N. R. & Gottlieb, R. A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281, 29776-29787 (2006). (Pubitemid 44536987)
29. Passani, M. B. & Blandina, P. Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol. Sci. 32, 242-249 (2011).
30. Garbarg, M., Barbin, G., Rodergas, E. & Schwartz, J. C. Inhibition of histamine synthesis in brain by alpha-fluoromethyl histidine, a new irreversible inhibitor: in vitro and in vivo studies. J. Neurochem. 35, 1045-1052 (1980). (Pubitemid 11198277)
31. Tyagarajan, S. K. et al. Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin. Proc. Natl Acad. Sci. USA 108, 379-384 (2011).
32. Maeda, K. et al. CLIC4 interacts with histamine H3 receptor and enhances the receptor cell surface expression. Biochem. Biophys. Res. Commun. 369, 603-608 (2008).
33. Zhong, J. et al. Inhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation. PLoS One 7, e39378 (2012).
34. Giovannini, M. G. et al. Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J. Neurosci. 23, 9016-9023 (2003). (Pubitemid 37243802)
35. Hu, W. W. & Chen, Z. Role of histamine and its receptors in cerebral ischemia. ACS Chem. Neurosci. 3, 238-247 (2012).
36. Irisawa, Y., Adachi, N., Liu, K., Arai, T. & Nagaro, T. Alleviation of ischemia-induced brain edema by activation of the central histaminergic system in rats. J. Pharmacol. Sci. 108, 112-123 (2008).
37. Adachi, N. Cerebral ischemia and brain histamine. Brain Res. Brain Res. Rev. 50, 275-286 (2005). (Pubitemid 41654398)
38. Motoki, A., Adachi, N., Semba, K., Liu, K. & Arai, T. Reduction in brain infarction by augmentation of central histaminergic activity in rats. Brain Res. 1066, 172-178 (2005). (Pubitemid 41790741)
39. Takahashi, K., Suwa, H., Ishikawa, T. & Kotani, H. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J. Clin. Invest. 110, 1791-1799 (2002). (Pubitemid 36076486)
40. Bhowmik, M., Khanam, R. & Vohora, D. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br. J. Pharmacol. 167, 1398-1414 (2012).
41. Nagoshi, T. et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 115, 2128-2138 (2005). (Pubitemid 41134154)
42. Mariottini, C. et al. Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults. J. Neurochem. 110, 1469-1478 (2009).
43. Chiang, G. G. & Abraham, R. T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485-25490 (2005). (Pubitemid 40962253)
44. Zhang, X. et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 9, 1321-1333 (2013).
45. Schlicker, E., Malinowska, B., Kathmann, M. & Gothert, M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 8, 128-137 (1994). (Pubitemid 24103046)
46. Hiraga, N., Adachi, N., Liu, K., Nagaro, T. & Arai, T. Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur. J. Pharmacol. 557, 236-244 (2007). (Pubitemid 46186286)
47. Fernandez-Salas, E. et al. mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol. Cell Biol. 22, 3610-3620 (2002). (Pubitemid 34525205)
48. Liu, L. et al. Improved learning and memory of contextual fear conditioning and hippocampal CA1 long-term potentiation in histidine decarboxylase knock-out mice. Hippocampus 17, 634-641 (2007). (Pubitemid 47292034)
49. Fan, Y. Y. et al. Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice. J. Cereb. Blood Flow Metab. 31, 305-314 (2011).
50. Longa, E. Z., Weinstein, P. R., Carlson, S. & Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91 (1989). (Pubitemid 19040218)
51. Ashwal, S., Tone, B., Tian, H. R., Cole, D. J. & Pearce, W. J. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29, 1037-1046 (1998).
52. Shen, Y. et al. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic. Bio. Med. 48, 727-735 (2010).
53. Wang, R. et al. Oxygen-glucose deprivation induced glial scar-like change in astrocytes. PLoS One 7, e37574 (2012).